SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-006395
Filing Date
2022-04-29
Accepted
2022-04-29 09:15:47
Documents
127
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F tmb-20211231x20f.htm   iXBRL 20-F 3866615
2 EX-8.1 tmb-20211231xex8d1.htm EX-8.1 8725
3 EX-12.1 tmb-20211231xex12d1.htm EX-12.1 13568
4 EX-12.2 tmb-20211231xex12d2.htm EX-12.2 13486
5 EX-13.1 tmb-20211231xex13d1.htm EX-13.1 17077
6 EX-15.1 tmb-20211231xex15d1.htm EX-15.1 2863
7 EX-15.2 tmb-20211231xex15d2.htm EX-15.2 2843
8 GRAPHIC tmb-20211231x20f003.jpg GRAPHIC 28051
9 GRAPHIC tmb-20211231x20f002.jpg GRAPHIC 40176
10 GRAPHIC tmb-20211231x20f006.jpg GRAPHIC 33653
11 GRAPHIC tmb-20211231x20f010.jpg GRAPHIC 51913
12 GRAPHIC tmb-20211231x20f001.jpg GRAPHIC 59893
13 GRAPHIC tmb-20211231x20f005.jpg GRAPHIC 75376
14 GRAPHIC tmb-20211231x20f009.jpg GRAPHIC 66575
15 GRAPHIC tmb-20211231x20f008.jpg GRAPHIC 15492
16 GRAPHIC tmb-20211231x20f007.jpg GRAPHIC 36264
17 GRAPHIC tmb-20211231x20f011.jpg GRAPHIC 42354
18 GRAPHIC tmb-20211231x20f004.jpg GRAPHIC 43371
  Complete submission text file 0001558370-22-006395.txt   14850518

Data Files

Seq Description Document Type Size
19 EX-101.SCH tmb-20211231.xsd EX-101.SCH 105863
20 EX-101.CAL tmb-20211231_cal.xml EX-101.CAL 79328
21 EX-101.DEF tmb-20211231_def.xml EX-101.DEF 313468
22 EX-101.LAB tmb-20211231_lab.xml EX-101.LAB 673240
23 EX-101.PRE tmb-20211231_pre.xml EX-101.PRE 529110
121 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211231x20f_htm.xml XML 2720688
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36622 | Film No.: 22870739
SIC: 2834 Pharmaceutical Preparations